Correction: MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcome.
作者信息
Taeb Shahram, Rostamzadeh Davoud, Amini Seyed Mohammad, Rahmati Mohammad, Eftekhari Mohammad, Safari Arash, Najafi Masoud
机构信息
Department of Radiology, School of Paramedical Sciences, Guilan University of Medical Sciences, Rasht, Iran.
Department of Immunology, University of Connecticut Health Center, Farmington, CT, USA.
出版信息
Cancer Cell Int. 2024 Aug 3;24(1):274. doi: 10.1186/s12935-024-03461-8.
Abstract
摘要
相似文献
1
Correction: MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcome.更正：微小RNA靶向mTOR作为治疗剂以改善放疗效果。
Cancer Cell Int. 2024 Aug 3;24(1):274. doi: 10.1186/s12935-024-03461-8.
2
MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcome.微小RNA靶向mTOR作为治疗药物以改善放疗效果。
Cancer Cell Int. 2024 Jul 4;24(1):233. doi: 10.1186/s12935-024-03420-3.
3
miR-99b-targeted mTOR induction contributes to irradiation resistance in pancreatic cancer.miR-99b靶向的mTOR诱导促进胰腺癌的辐射抗性。
Mol Cancer. 2013 Jul 25;12:81. doi: 10.1186/1476-4598-12-81.
4
Targeting MicroRNAs in Prostate Cancer Radiotherapy.靶向前列腺癌放射治疗中的 microRNAs。
Theranostics. 2017 Jul 23;7(13):3243-3259. doi: 10.7150/thno.19934. eCollection 2017.
5
microRNA-mediated regulation of mTOR complex components facilitates discrimination between activation and anergy in CD4 T cells.微小RNA介导的mTOR复合体组分调控促进CD4 T细胞中激活与无反应性的区分。
J Exp Med. 2014 Oct 20;211(11):2281-95. doi: 10.1084/jem.20132059. Epub 2014 Oct 13.
6
To combine or not combine: the role of radiotherapy and targeted agents in the treatment for renal cell carcinoma.联合还是不联合：放疗与靶向药物在肾细胞癌治疗中的作用
World J Urol. 2014 Feb;32(1):59-67. doi: 10.1007/s00345-013-1068-5. Epub 2013 May 8.
7
Augmenting the therapeutic window of radiotherapy: A perspective on molecularly targeted therapies and nanomaterials.增强放射治疗的治疗窗口：从分子靶向治疗和纳米材料的角度来看。
Radiother Oncol. 2020 Sep;150:225-235. doi: 10.1016/j.radonc.2020.06.041. Epub 2020 Jun 27.
8
Role of mTORC1 and mTORC2 in Breast Cancer: Therapeutic Targeting of mTOR and Its Partners to Overcome Metastasis and Drug Resistance.mTORC1 和 mTORC2 在乳腺癌中的作用：靶向 mTOR 及其伙伴克服转移和耐药性的治疗。
Adv Exp Med Biol. 2019;1152:283-292. doi: 10.1007/978-3-030-20301-6_15.
9
Tailoring mTOR-based therapy: molecular evidence and clinical challenges.个体化 mTOR 靶向治疗：分子证据与临床挑战。
Pharmacogenomics. 2013 Sep;14(12):1517-26. doi: 10.2217/pgs.13.143.
10
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer.针对人类癌症的靶向治疗，攻击 PI3K/Akt/mTOR 信号通路。
Semin Cancer Biol. 2022 Oct;85:69-94. doi: 10.1016/j.semcancer.2021.06.019. Epub 2021 Jun 25.
本文引用的文献
1
MicroRNAs targeted mTOR as therapeutic agents to improve radiotherapy outcome.微小RNA靶向mTOR作为治疗药物以改善放疗效果。
Cancer Cell Int. 2024 Jul 4;24(1):233. doi: 10.1186/s12935-024-03420-3.
Zotero 插件